Recommended
Breaking News
FDA Approves Expanded Label for Iluvien to Include Chronic Noninfectious Uveitis
Mar 17, 2025
The FDA has approved an expanded label for Iluvien, allowing its use for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye, ANI Pharmaceuticals announced in a press release.
Atsena Therapeutics Receives FDA Fast Track Designation for ATSN-201 Gene Therapy in X-Linked Retinoschisis
Mar 13, 2025
Atsena Therapeutics has been granted Fast Track designation by the FDA for ATSN-201, its investigational gene therapy designed to treat X-linked retinoschisis (XLRS), a rare inherited retinal disease with no approved treatments.
Sydnexis Announces FDA Acceptance of NDA for SYD-101 in Pediatric Myopia Treatment
Mar 12, 2025
Sydnexis has reached a significant regulatory milestone with the FDA’s acceptance of its New Drug Application (NDA) for SYD-101, a potential first-in-class pharmaceutical treatment for the progression of pediatric myopia in the United States.
.jpg)
Industry News
Sydnexis Receives Positive CHMP Opinion for SYD-101 to Treat Pediatric Myopia in Europe
Apr 02, 2025
Sydnexis has announced a significant milestone with the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) granting a positive opinion for its low-dose atropine formulation, SYD-101.
Pantheon Vision Partners with EyeDeal Medical to Develop Bioengineered Corneal Implant
Mar 28, 2025
Pantheon Vision has announced a strategic partnership with EyeDeal Medical to co-develop a bioengineered artificial corneal implant, aiming to eliminate the global dependency on human donor corneal tissue and ultimately eradicate corneal blindness.
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease
Mar 28, 2025
Alcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech company focused on developing innovative cell therapies for the treatment of eye diseases.
Ophthalmic Research News
NIH Researchers Demonstrate Promise of PEDF-Based Eye Drops for Inherited Retinal Diseases
Mar 24, 2025
A team at the National Eye Institute (NEI), part of the NIH, has developed and tested eye drops containing fragments of pigment epithelium-derived factor (PEDF)—a naturally occurring protein in the eye—to delay retinal degeneration in animal models.
Veterans Study Uncovers New Genetic Risk Factors for Age-Related Macular Degeneration
Mar 21, 2025
A large-scale U.S. veterans study has identified new genetic markers linked to age-related macular degeneration (AMD), highlighting differences across ancestry groups and offering new insights for treatment development.
Eye Care in Local Clinics Can Reduce NHS Patient Wait Times and Optimize Resources
Mar 20, 2025
A study has found that shifting eye care services from hospital eye services (HES) to local optometric clinics significantly reduces patient wait times and optimizes NHS resources.
Ophthalmic Blog
AI in Ophthalmology: Top Artificial Intelligence Tools Transforming Eye Health
Mar 07, 2025
The AI in ophthalmology sector is evolving rapidly, introducing Artificial Intelligence tools in ophthalmology that enhance diagnostic accuracy, efficiency, and accessibility.
2024 Recap: Top 8 Groundbreaking Innovations in Eye Disease Therapies and Technologies
Dec 23, 2024
The year 2024 has been a remarkable period for advancements in ophthalmology, with groundbreaking innovations reshaping the landscape of eye disease treatment and diagnosis.
2024 Recap: Top 8 FDA Approvals in Ophthalmology
Dec 16, 2024
The year 2024 has been a pivotal one for ophthalmology, with several novel FDA approvals introducing innovative treatments and technologies to the field
Ophthalmology Breaking News Subscribe